|Articles|November 21, 2016
TKL Research Agrees to Sell Clinical Trials Division
TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division to QuintilesIMS.
Advertisement
TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division (CTD) to QuintilesIMS. TKL Research will retain its Research Clinics Division and its CTD will become part of Novella Clinical, a subsidiary of QuintilesIMS.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
2
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
3
eClinical Technology: Misconceptions, Challenges, and Opportunities
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5